VHPB Centre for Evaluation of Vaccination (CEV) |
Executive Secretary Administrative and Scientific Secretariat |
privacy statement
|
Istanbul, Turkey, November 13-14, 2009
Thursday, November 12, 2009
Session 1 Opening and objectives
Chair: Selim Badur, Nedret Emiroglu
Session 2 Overview of health care system and communicable disease prevention and control in Turkey
Chair: Selim Badur, Nedret Emiroglu
09.30 – 10.30
Communicable diseases surveillance systems and immunization service delivery 881Kb (.pdf)
Dr Ümit Özdemirer
10.30 – 10.45 Coffee Break
Session 3 Epidemiology of viral hepatitis in Turkey
Chair: Nicole Guérin, Mark Kane
10.45 – 11.05
The epidemiological situation of hepatitis B and D in Turkey 707Kb (.pdf)
Arzu Sayiner
11.05 – 11.25
The hepatitis A vaccination in Turkey: targeted versus universal 1,2Mb (.pdf)
Mehmet Ceyhan
11.25 – 11.45
The epidemiological situation of hepatitis C in Turkey 1,1Mb (.pdf)
Selda Erensoy
11.45 – 12.05 Discussion
12.05 – 13.30 Lunch
Chair: Heléne Norder, Wolfgang Jilg
13.30 – 13.50
Molecular epidemiology of viral hepatitis in Turkey 3,7Mb (.pdf)
Hakan Abacioglu
11.05 – 11.25
Epidemiology of chronic hepatitis and cirrhosis in Turkey 2,1Mb (.pdf)
Cihan Yurdaydin
11.25 – 11.45
Mutants problems in Turkey 1Mb (.pdf)
Ulus Akarca
14.30 – 14.50 Discussion
14.50 – 15.25 Coffee break
Session 4 Review of progress achieved in hepatitis prevention and control in Turkey
Chair: Francoise Roudot-Thoraval, Koen Van Herck
15.25 – 15.45
HBV immunization policies and lessons learnt after 10 years of implementation 2,5Mb (.pdf)
Dr Ümit Özdemirer
15.45 – 16.05
Results from the blood bank screening in Turkey 284Kb (.pdf)
Yasemin Heper
16.05 –16.25
Approach of NGO's 934Kb (.pdf)
Nurdan Tözün
16.25 – 16.45
Therapeutic algorithm in the treatment of chronic hepatitis in Turkey 486Kb
Yilmaz Çakaloglu
16.45 – 17.05 Discussion
17.05 End of the Day
Friday, November 13, 2009
Session 5 Different aspects of viral hepatitis in Turkey
Chair: Angela Dominguez, Daniel Lavanchy
09.00 – 09.20
Viral hepatitis and Transplantation. 1,8Mb (.pdf)
Zeki Karasu
09.20 – 09.40
Victimes of human trafficking and viral hepatitis. 888KB (pdf)
Muthar Çokar
09.40 – 10.00
Economic aspects of viral hepatitis in Turkey 874Kb (.pdf)
Levent Akin
10.00 – 10.20
Healthcare workers and viral hepatitis 479Kb (.pdf)
Bülent Deðertekin
10.20 – 10.40 Discussion
10.40 – 11.00 Coffee break
Session 6 Evaluation of viral hepatitis prevention and control measures
Chair: Johannes Hallauer, Steven Wiersma
11.00 – 11.30
Global HCV prevention and control measures: lesson learnt and opportunities 403Kb (.pdf)
Daniel Lavanchy
11.30 – 12.00
HBV prevention and control programmes in Turkey and in the European Region of WHO 671Kb (.pdf)
Nedret Emiroðlu
12.00 – 12.30
Speeding-up Hepatitis B and C control in WHO Eastern Mediterranean Region 2,8Mb (.pdf)
Ezzeddine Mohsni
12.30 – 12.40 Discussion
12.40 – 14.15 Lunch
Session 7 Conclusions of the meeting
Chair: John Ward, Daniel Shouval
14.15 – 14.45
Presentation of the VHPB meeting conclusions 87Kb (.pdf)
D. FitzSimons
15.00 Close of the meeting